Extendicare (TSE:EXE) PT Raised to C$9.50

Extendicare (TSE:EXEGet Free Report) had its price target upped by research analysts at TD Securities from C$9.00 to C$9.50 in a report issued on Wednesday, BayStreet.CA reports. The brokerage currently has a “hold” rating on the stock. TD Securities’ target price indicates a potential upside of 6.98% from the company’s previous close.

Separately, Royal Bank of Canada lifted their price objective on Extendicare from C$8.50 to C$9.50 in a report on Monday, August 19th.

Read Our Latest Stock Analysis on Extendicare

Extendicare Price Performance

TSE EXE opened at C$8.88 on Wednesday. Extendicare has a fifty-two week low of C$5.75 and a fifty-two week high of C$9.16. The stock’s 50-day moving average is C$7.80 and its two-hundred day moving average is C$7.51. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The firm has a market cap of C$741.21 million, a P/E ratio of 13.06 and a beta of 1.26.

Extendicare (TSE:EXEGet Free Report) last posted its quarterly earnings data on Monday, August 12th. The company reported C$0.29 EPS for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. The business had revenue of C$348.48 million for the quarter, compared to analyst estimates of C$360.20 million.

About Extendicare

(Get Free Report)

Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.

Featured Stories

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.